Discuss in detail about ADA diabetes guidelines 2026, scoring, classifications, anaesthetic implications and considerations
ADA "Standards of Care" diabetes 2025 2026
ADA diabetes standards of care 2026 classification guidelines updates
ADA 2026 diabetes classification diagnosis scoring criteria type 1 type 2 prediabetes HbA1c glucose
"diabetes mellitus" AND "perioperative" AND "anesthesia" AND "glycemic"
ADA 2026 diabetes perioperative hospital blood glucose management HbA1c targets insulin anaesthesia GLP-1
ADA 2026 standards of care diabetes hospital perioperative anaesthesia GLP-1 insulin management section 16
| Section | Topic |
|---|---|
| 1 | Evidence Grading (A/B/C/E system) |
| 2 | Diagnostic Criteria (glucose, HbA1c, OGTT thresholds) |
| 3 | Classification: T1DM, T2DM, GDM, Other — including T1DM staging table and cancer drug–induced hyperglycaemia |
| 4 | Glycaemic Targets (HbA1c, TIR, preprandial/postprandial) |
| 5 | Pharmacotherapy (GLP-1 RA expansions, SGLT-2i, DPP-4) |
| 6 | Perioperative Goals — two new 2026 recommendations: HbA1c <8% pre-surgery; glucose 100–180 mg/dL intraoperatively |
| 7 | Anaesthetic Implications — airway (cheiroarthropathy), gastroparesis, GLP-1 RA risks, drug management, intraoperative monitoring, regional vs. general anaesthesia |
| 8 | Transplant perioperative diabetes |
| 9 | DKA and HHS — perioperative recognition and management |
| 10 | Summary table of 2026 anaesthesia-relevant changes |